Fukushima Medical University · Department of Medical Oncology

Research keywords免疫関連有害事象・乳癌・エストロゲン受容体・免疫チェックポイント阻害薬・HLA遺伝子型・抗体薬物複合体

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event.2024 · Sasaki E, Natori Y, Tokuda E, Kimura-Tsuchiya R, Suga J, Kanazawa K, Koguchi T, Kikuchi N, Okabe N, Murono S, Tachibana K, Soeda S, Shimabukuro M, Saji S.
• E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer2023 · Natori Y, Suga J, Tokuda E, Tachibana K, Imai J, Honma R, Azami Y, Noda M, Sasaki E, Watanabe S, Ohtake T, Saji S.
• がん免疫療法の診断と治療の現状と展望：がん抗体療法の進歩：乳がんHER2抗体薬物複合体などの抗体療法の現状と進歩2023 · 名取 穣, 佐治 重衡
• A rare case of recurrent ovarian cancer with TPM3-NTRK1 gene rearrangement: A case report.2022 · Endo Y, Watanabe T, Saito M, Saito K, Suzuki R, Sano H, Natori Y, Sasaki E, Ueda M, Kamo N, Furukawa S, Soeda S, Kono K, Saji S, Fujimori K.

• 癌免疫療法により生じる免疫関連有害事象の発症予測マーカーの確立

• Official profile
• ORCID